Online citations, reference lists, and bibliographies.
← Back to Search

Algesia And Local Responses Induced By Neurokinin A And Substance P In Human Skin And Temporal Muscle

U. Pedersen-Bjergaard, L. B. Nielsen, K. Jensen, L. Edvinsson, J. Olesen
Published 1989 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Neurokinin A (NKA), substance P (SP) and the two peptides combined (SP + NKA) were injected intracutaneously on the forearm and into the temporal muscle of healthy volunteers. Pain intensity, cutaneous wheal and flare responses and tenderness of the temporal muscle were quantitated. SP but not NKA induced cutaneous pain. This relates the algesic effect of SP to the specific N-terminal amino acid sequence of the peptide, not shared by NKA. NKA, however, potentiated the algesic effect of SP as SP + NKA induced a significantly prolonged cutaneous pain sensation. Both peptides induced wheals, but only SP induced flare. These results confirm previous studies relating wheal formation to the identical C-terminal amino acid sequence of the two peptides and flare reaction to the N-terminal part of SP. Injections into the temporal muscle did not cause pain or tenderness.
This paper references
10.1016/0304-3940(87)90194-7
Trigeminal origin of β-preprotachykinin products in feline pial blood vessels
K. Saito (1987)
10.1139/Y86-224
Evidence that substance P may be a modulator rather than a transmitter of noxious mechanical stimulation.
M. Sweeney (1986)
10.1016/0014-2999(85)90750-2
Comparison of the effects of substance P and substance K on blood pressure, salivation and urinary bladder motility in urethane-anaesthetized rats.
C. Maggi (1985)
10.1016/0167-0115(82)90057-X
Use of substance P fragments to differentiate substance P receptors of different tissues
M. Piercey (1982)
10.1111/J.1365-2125.1988.TB03302.X
Comparison of neurokinin A and substance P on cardiovascular and airway function in man.
T. Evans (1988)
10.1016/0166-2236(85)90073-6
Multiple tachykinin receptors
R. Quirion (1985)
10.1111/1523-1747.EP12515092
Flare and itch induced by substance P in human skin.
O. Haegermark (1978)
10.1016/0006-8993(78)91105-8
The central and peripheral ends of the substance P-containing sensory neurones in the rat trigeminal system
A. Cuello (1978)
10.1016/0022-510X(87)90172-9
Trends in cluster headache: F. Sicuteri, L. Vecchiet, M. Fanciullacci (eds.), Excerpta Medica, international congress series 731, Elsevier Science Publishers B.V., Amsterdam, 1987
G. Bruyn (1987)
10.1016/0024-3205(84)90087-0
Substance K: a novel mammalian tachykinin that differs from substance P in its pharmacological profile.
H. Nawa (1984)
10.1177/03331024850050S301
Nociception and Pressure-Pain-Threshold in the Temporal Muscle following Local Injection of Bradykinin and Serotonin
K. Jensen (1985)
10.1159/000138190
Histamine release and local responses of rat and human skin to substance P and other mammalian tachykinins.
P. Devillier (1986)
10.1111/j.1476-5381.1984.tb10773.x
Hyperalgesia produced by intrathecal substance P and related peptides: desensitization and cross desensitization
S. Moochhala (1984)
10.1016/0028-3908(81)90091-5
The role of the N-terminal tetrapeptide in the histamine releasing action of substance P
N. Mazurek (1981)
10.1016/0014-5793(87)80932-8
Mast cell activation — a receptor‐independent mode of substance P action?
H. Repke (1987)
10.1111/J.1748-1716.1981.TB06770.X
Substance P in trigeminal nerve endings: occurrence and release.
E. Brodin (1981)
10.1002/ANA.410160202
The neurobiology of vascular head pain
M. Moskowitz (1984)
10.1113/jphysiol.1983.sp014543
Structure‐activity relationships for some substance P‐related peptides that cause wheal and flare reactions in human skin.
J. Foreman (1983)
10.1038/335073a0
Substance P regulates the vasodilator activity of calcitonin gene-related peptide
S. Brain (1988)
10.1177/03331024870070S604
Substance P And Nociception In The Human Temporal Muscle
K. Jensen (1987)
10.1016/0304-3959(86)90235-6
Pressure-pain threshold in human temporal region. Evaluation of a new pressure algometer
K. Jensen (1986)
10.1093/BRAIN/108.2.517
Substance P and the sensory innervation of intracranial and extracranial feline cephalic arteries. Implications for vascular pain mechanisms in man.
T. Norregaard (1985)
10.1016/0166-2236(80)90036-3
Substance P and pain: an updating
J. Henry (1980)
10.1002/ANA.410200409
Localization and effects of neuropeptide Y, vasoactive intestinal polypeptide, substance P, and calcitonin gene–related peptide in human temporal arteries
I. Jansen (1986)
10.1007/BF00500282
Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation
F. Lembeck (2004)
10.1111/1523-1747.EP12470339
Substance P-induced histamine release in human cutaneous mast cells.
J. Ebertz (1987)
10.1007/BF00500821
On the actions of substance P, somatostatin, and vasoactive intestinal polypeptide on rat peritoneal mast cells and in human skin
W. Piotrowski (2004)
10.1007/BF00495297
Neurokinin A-like immunoreactivity in rat primary sensory neurons; coexistence with substance P
C. Dalsgaard (2004)
10.1093/OXFORDJOURNALS.BMB.A072189
Peptides and neurogenic inflammation.
J. Foreman (1987)
10.1016/0304-3959(86)90162-4
Peptide-containing nerve fibres in human extracranial tissue: a morphological basis for neuropeptide involvement in extracranial pain?
R. Uddman (1986)
10.1016/0304-3959(82)90096-3
Substance P reduces tail-flick latency: Implications for chronic pain syndromes
Kiran Yasphal (1982)
10.1016/0304-3940(86)90453-2
Nociceptive behavior after intrathecal injections of substance P, neurokinin A and calcitonin gene-related peptide in mice
R. Gamse (1986)



This paper is referenced by
10.1186/1744-8069-3-30
Roles of TRPV1 and neuropeptidergic receptors in dorsal root reflex-mediated neurogenic inflammation induced by intradermal injection of capsaicin
Q. Lin (2007)
10.1111/j.1600-0404.1993.tb08074.x
References
(1993)
10.1096/fj.01-0939fje
Loss of dipeptidylpeptidase IV activity in chronic rhinosinusitis contributes to the neurogenic inflammation induced by substance P in the nasal mucosa
E. Grouzmann (2002)
10.1007/978-3-662-53994-1_6
Masticatory Muscle Pain Biomarkers
M. Ernberg (2017)
10.1007/s00101-002-0296-7
Warum versagen Substanz P (NK1)-Rezeptorantagonisten in der Schmerztherapie?
M. Herbert (2002)
10.1007/s10194-010-0214-3
Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP
H. Schytz (2010)
10.1177/0333102491011S1114
Effects of Neurokinin a in Human Skin.
K. Jensen (1991)
10.1201/9781420042566-c14
Methods for induction and assessment of pain in humans with clinical and pharmacological examples
T. Graven-Nielsen (2001)
10.1007/s004820050048
Substanz P, Somatostatin und monoaminerge Transmitter in der Zerebrospinalflüssigkeit von Patienten mit chronischer idiopathischer Trigeminusneuralgie
M. Strittmatter (2006)
10.1007/s40263-019-00630-6
Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets
K. Haanes (2019)
Induction and modulation of referred muscle pain in humans
R. Laursen (1999)
10.1016/0196-9781(89)90169-1
Effect of neurokinin A on human temporal muscle blood flow
C. Tuxen (1989)
10.1016/S0304-3959(99)00026-3
Experimental human muscle pain and muscular hyperalgesia induced by combinations of serotonin and bradykinin
V. Babenko (1999)
Importancia de la sustancia P y su receptor NK-1R en el cáncer de tiroides
Inmaculada Isorna Retamino (2016)
10.1016/0196-9781(91)90220-J
Differential processing of substance P and neurokinin A by plasma dipeptidyl(amino)peptidase IV, aminopeptidase M and angiotensin converting enzyme
L. Wang (1991)
10.1080/17453674.1998.11744792
Degenerative conditions of the spine. Current diagnostic procedures and treatment modalities.
S. Garfin (1998)
Injection of Capsaicin in Rats C-Primary Nociceptive Afferents After Intradermal - and δ Sympathetic Modulation of Activity in A
J NeurophysiolRen (2015)
10.1016/0735-1097(94)90306-9
Substance P potentiates the algogenic effects of intraarterial infusion of adenosine.
A. Gaspardone (1994)
10.1007/978-3-0348-8131-9_5
Models of neurogenic inflammation as it relates to migraine
U. Reuter (2002)
10.1111/1523-1747.EP12607047
Axon-reflex-mediated vasodilatation in the psoriatic plaque?
A. Krogstad (1995)
10.1097/00002508-200103000-00003
Referred Muscle Pain: Basic and Clinical Findings
L. Arendt-Nielsen (2001)
10.1111/j.1476-5381.2010.00757.x
Increased morphine analgesia and reduced side effects in mice lacking the tac1 gene
A. Bilkei-Gorzo (2010)
10.1016/S0301-0082(98)00048-3
The induction of pain: an integrative review
M. Millan (1999)
10.1016/0304-3959(93)90027-M
Nociception from skeletal muscle in relation to clinical muscle pain
S. Mense (1993)
10.1046/j.1468-2982.1991.1104175.x
Pain, Tenderness, Wheal and Flare Induced by Substance-P, Bradykinin and 5-Hydroxytryptamine in Humans
K. Jensen (1991)
10.1016/0165-6147(94)90075-2
Nitric oxide is a key molecule in migraine and other vascular headaches.
J. Olesen (1994)
10.1007/978-3-0348-8131-9
Migraine: A Neuroinflammatory Disease?
M. J. Parnham (2002)
10.1046/j.1526-4610.1997.3704211.x
Cerebrospinal Fluid Neuropeptides and Monoaminergic Transmitters in Patients With Trigeminal Neuralgia
Matthias Strittmatter (1997)
The Effect of Lumbar Spine Osteoarthritis on the Manifestation of Central Sensitization and Neurogenic Inflammation in Musculoskeletal Tissues in Rats
Felipe Coutinho Kullmann Duarte (2019)
10.1016/0196-9781(91)90022-H
Calcitonin gene-related peptide, neurokinin A and substance P: Effects on Nociception and neurogenic inflammation in human skin and temporal muscle
U. Pedersen-Bjergaard (1991)
10.1016/S0143-4179(97)90038-X
Substance P is not involved in vascular nociception in humans
H. Holthusen (1997)
10.1300/J094V05N01_04
Experimental Muscle Pain: A Quantitative Study of Local and Referred Pain in Humans Following Injection of Hypertonic Saline
T. Graven-Nielsen (1997)
See more
Semantic Scholar Logo Some data provided by SemanticScholar